Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2

Benzer Materyaller

• Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial
  Yazar:: Araki, Kyohei, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
  Yazar:: Miyata, Yasuyoshi, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial
  Yazar:: Miyata, Yasuyoshi, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Mechanisms Underlying the Inhibition of Tyrosine Kinase Inhibitor-Induced Anorexia and Fatigue by Royal Jelly in Renal Cell Carcinoma Patients and the Correlation between Macrophage Colony Stimulating Factor and Inflammatory Mediators
  Yazar:: Yuno, Tsutomu, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Recovery from life-threatening pelvic organ prolapse in an 80-year-old Japanese woman: a case report
  Yazar:: Matsuo, Tomohiro, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)